Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neurotoxicity Syndromes × haloperidol decanoate × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neurotoxicity Syndromes 1 Hematologic Neoplasms 1 Delirium 1

Interventions

haloperidol decanoate 1 fludarabine phosphate 1 fludarabine 1 Temozolomide 1 Surveys and Questionnaires 1 Simvastatin 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Lorazepam 1 Dexamethasone 1 Cyclophosphamide 1 Bendamustine Hydrochloride 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01949662 2026-02-13

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

93 enrolled 14 charts

Other hematologic neoplasm

Delirium, Hematologic Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡